
    
      This is an open-label, phase I/II study of intra-cerebral administration of
      adenovirus-associated viral vector containing the human NAGLU cDNA to children suffering from
      Sanfilippo type B syndrome.

      Four patients, 18 months up to the 5th birthday, have been included.

      The inclusion period will be 8 to 12 months. The duration of follow-up for each patient is 1
      year post-surgery. The duration of the first extension phase is 18 months. The duration of
      the second extension phase is 36 months. Therefore, the maximum time of the follow-up will be
      66 months
    
  